Tocagen (TOCA) IPO Opens Modestly Higher

Go back to Tocagen (TOCA) IPO Opens Modestly Higher

Tocagen Announces Pricing of Initial Public Offering

April 13, 2017 8:30 AM UTC

SAN DIEGO, April 13, 2017 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the pricing of its initial public offering of 8,500,000 shares of common stock at a public offering price of $10.00 per share. The shares are expected to begin trading on the NASDAQ Global Select Market on April 13, 2017 under the ticker symbol "TOCA." In addition, Tocagen has granted the underwriters a 30-day option to purchase up to an additional 1,275,000 shares of common stock at the initial public offering price.

Leerink Partners LLC,... More